- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07570485
Feasibility Assessment of Adapted Physical Activity in Patients Treated for a Brain Tumor (APATC)
The goal of this clinical trial is to assess the feasibility of an adapted physical activity (APA) program in adult patients (≥18 years) with primary brain tumors, regardless of tumor type, grade, treatment stage, or the presence of motor, sensory, attention, concentration, or memory deficits.
The main question it aims to answer is:
What is the effective adherence rate to an APA program among eligible patients with primary brain tumors?
Additional questions include:
- What is the observance rate (number of sessions completed, intensity achieved, and duration) during the 3-month supervised APA program?
- What is the retention rate (proportion of patients completing the program and continuing APA beyond the initial period)?
- What is the impact of APA on quality of life, anxiety-depression, and cancer-related symptoms (measured via QLQ-BN20, HADS, and MFI-20 questionnaires at baseline, 3, and 4 months)?
Participants will:
- Undergo a 3-month supervised APA program (with possible continuation beyond this period).
- Use connected watches to monitor physical activity (if they accept the general conditions of use).
- Complete self-questionnaires (IPAQ, BREQ-2, QPP, QLQ-BN20, HADS, MFI-20) at inclusion, 3 months, and 4 months.
- Be followed for a total of 4 months after inclusion.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Valérie JOLAINE
- Phone Number: 0299253036
- Email: v.jolaine@rennes.unicancer.fr
Study Locations
-
-
-
Rennes, France, 35000
- Centre Eugene Marquis
-
Contact:
- Valérie JOLAINE
- Phone Number: 0299253036
- Email: v.jolaine@rennes.unicancer.fr
-
Principal Investigator:
- Elodie VAULEON, DR
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Men or women ≥ 18 years old,
- Receiving medical oncology treatment at the CLCC Eugène Marquis,
- Diagnosed with a primary brain tumour, regardless of diagnosis, grade or treatment,
- Possible motor, sensory, attention, concentration, or memory deficits,
- Patients who accept the general terms of use for connected watches
- Patients affiliated with or covered by the French social security system,
- Patients who have received information and signed informed consent (or their legal representative),
Exclusion Criteria:
- WHO score ≥ 3
- Comprehension disorders that prevent participation in adapted physical activity
- Pregnant or breastfeeding women
- Patients without the necessary devices to use a smartwatch (smartphone, tablet or computer),
- Patients deprived of liberty, under guardianship, or curatorship, or subject to any other administrative safeguard measure.
Patients unable to comply with the study schedule for social, medical, or psychological reasons.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PA with Strength Sheets + Walking Recommendation
Patients receive 2 strength exercise sheets to perform weekly at home + a recommendation to walk regularly (30 min/day).
No supervised sessions.
Activity is self-monitored via connected watch.
|
Adapted Physical Activity (APA) is a tailored exercise program designed for individuals with specific health conditions, such as brain tumors.
It aims to improve physical function, quality of life, and overall well-being while ensuring safety and feasibility.
APA is supervised by trained professionals and adapted to each individual's abilities and needs.
|
|
Experimental: APA with Strength Sheet + Group Videoconference Session
Patients receive 1 strength exercise sheet to perform weekly at home + 1 hour of group training via videoconference per week.
The videoconference session content matches the 2nd strength sheet from Arm 1. Activity is self-monitored via connected watch.
|
Adapted Physical Activity (APA) is a tailored exercise program designed for individuals with specific health conditions, such as brain tumors.
It aims to improve physical function, quality of life, and overall well-being while ensuring safety and feasibility.
APA is supervised by trained professionals and adapted to each individual's abilities and needs.
|
|
Experimental: APA with Strength Sheet + Individual Home Session
Patients receive 1 strength exercise sheet to perform weekly at home + 1 hour of individualized and personalized training at home per week.
The home session content matches the 2nd strength sheet from Arm 1. Activity is self-monitored via connected watch.
|
Adapted Physical Activity (APA) is a tailored exercise program designed for individuals with specific health conditions, such as brain tumors.
It aims to improve physical function, quality of life, and overall well-being while ensuring safety and feasibility.
APA is supervised by trained professionals and adapted to each individual's abilities and needs.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effective adherence rate to the Adapted Physical Activity (APA) program
Time Frame: Baseline to 4 months
|
The primary outcome is the proportion of eligible patients who participate in at least one APA session out of the total number of eligible patients solicited for inclusion.
This metric Evaluates the feasibility of APA implementation in brain tumor patients.
|
Baseline to 4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
APA program observance rate
Time Frame: Baseline to 4 months
|
Evaluated through the number of sessions completed, the number of sessions reaching the recommended intensity level, and the duration of sessions performed during the 3-month supervised period and the 1-month autonomous period.
|
Baseline to 4 months
|
|
Retention rate during the 3-month supervised APA period
Time Frame: Baseline to 3 months
|
Proportion of patients who complete the entire 3-month supervised APA program, reflecting their commitment and ability to sustain participation.
|
Baseline to 3 months
|
|
Retention Rate After Supervised APA Period
Time Frame: 4 months
|
Proportion of patients who continue APA beyond the initial 3-month supervised period, assessed at 4 months.
|
4 months
|
|
Reasons for early discontinuation of APA
Time Frame: Baseline to 4 months
|
Documentation of specific reasons (e.g., fatigue, disease progression, lack of motivation) for patients who discontinue APA prematurely.
|
Baseline to 4 months
|
|
uality of life assessment using QLQ-BN20 questionnaire (EORTC Quality of Life Questionnaire - Brain Neoplasm Module 20)
Time Frame: Baseline, 3 months, and 4 months
|
Evaluation of brain tumor-specific quality of life using the EORTC QLQ-BN20 questionnaire, which assesses symptoms and functional domains relevant to brain tumor patients.
|
Baseline, 3 months, and 4 months
|
|
Anxiety and depression assessment using HADS (Hospital Anxiety and Depression Scale) questionnaire
Time Frame: Baseline, 3 months, and 4 months
|
Evaluation of anxiety and depression levels using the Hospital Anxiety and Depression Scale (HADS), a validated tool for assessing psychological distress.
|
Baseline, 3 months, and 4 months
|
|
Fatigue assessment using MFI-20 (Multidimensional Fatigue Inventory-20) questionnaire
Time Frame: Baseline, 3 months, and 4 months
|
Evaluation of multidimensional fatigue (general, physical, mental, reduced motivation, and reduced activity) using the Multidimensional Fatigue Inventory (MFI-20).
|
Baseline, 3 months, and 4 months
|
|
Physical activity level assessment using IPAQ (International Physical Activity Questionnaire) questionnaire
Time Frame: Baseline, 3 months, and 4 months
|
Evaluation of physical activity intensity and frequency using the International Physical Activity Questionnaire (IPAQ), which classifies participants into low, moderate, or high activity levels.
|
Baseline, 3 months, and 4 months
|
|
Motivation for physical activity assessment using BREQ-2 -Behavioral Regulation in Exercise Questionnaire - Version 2) questionnaire
Time Frame: Baseline, 3 months, and 4 months
|
Evaluation of motivation types (intrinsic, identified, introjected, external) using the Behavioral Regulation in Exercise Questionnaire (BREQ-2).
|
Baseline, 3 months, and 4 months
|
|
Perceived enjoyment of physical activity assessment using PACES (Physical Activity Enjoyment Scale) questionnaire
Time Frame: Baseline, 3 months, and 4 months
|
Evaluation of enjoyment and satisfaction related to physical activity using the PACES questionnaire.
|
Baseline, 3 months, and 4 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Elodie VAULEON, Dr, Centre de lutte contre le cancer Eugène Marquis
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2025-4-79-002
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Tumor Adult
-
Technical University of MunichRecruiting
-
Ohio State University Comprehensive Cancer CenterCompletedAdult Brain TumorUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
GT Medical Technologies, Inc.RecruitingBrain Tumor | Brain Tumor, Recurrent | Brain Tumor, Primary | Brain Tumor - Metastatic | Brain Tumor, Adult: Glioblastoma | Brain Tumor, Adult MeningiomaUnited States
-
Mahidol UniversityUnknown
-
Brainlab AGNot yet recruitingNeurosurgery | Brain Tumor Adult | Craniotomy Tumor Removal Surgery | Surgical PlanningUnited States
-
National Cancer Institute (NCI)CompletedAdult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain Tumor | Adult Brain TumorUnited States
-
Center Eugene MarquisCompleted
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedAdult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Ependymoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult Oligodendroglioma | Adult Pineal Gland Astrocytoma | Recurrent Adult... and other conditionsUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAdult Diffuse Astrocytoma | Adult Ependymoma | Adult Mixed Glioma | Adult Oligodendroglioma | Adult Pineal Gland Astrocytoma | Recurrent Adult Brain Tumor | Adult Brain Stem Glioma | Adult Grade II Meningioma | Adult Meningeal Hemangiopericytoma | Adult Pineocytoma | Adult Brain Tumor | Adult Melanocytic LesionUnited States
Clinical Trials on adapted physical activity
-
Assistance Publique Hopitaux De MarseilleRecruiting
-
University Hospital, BordeauxNot yet recruiting
-
Centre Hospitalier Metropole SavoieRecruiting
-
Raincy Montfermeil Hospital GroupJanssen Cilag S.A.S.RecruitingInflammatory Bowel Disease (IBD) | Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)France
-
Hospices Civils de LyonNot yet recruiting
-
Centre Borelli UMR 9010Not yet recruitingAging | Fall | Motor Activity | Gait, Unsteady
-
WepromRecruitingDiffuse Large B Cell LymphomaFrance
-
University of Rennes 2Completed
-
Hong Kong Baptist UniversityCompleted